Glaxo Won't Block Generic Of Zantac Syrup
Cypress Pharmaceutical has reached a settlement agreement with a GlaxoSmithKline unit, putting to rest all disputes between the two companies related to the syrup form of the ulcer drug Zantac, Cypress...To view the full article, register now.
Already a subscriber? Click here to view full article